Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: A critical review of the literature

Federico Marchetti, Luisella Giglio, Manila Candusso, Dino Faraguna, Baroukh M. Assael

Research output: Contribution to journalArticle

Abstract

Aim: To assess the evidence supporting early antibiotic treatment in asymptomatic cystic fibrosis (CF) patients colonised by Pseudomonas aeruginosa (PA). Methods: We carried out a computerised (Medline, Embase) and hand search of journals for suitable publications. All English-language clinical studies regarding the efficacy of early antibiotic treatment on PA colonisation in asymptomatic patients were considered. Each eligible publications fitting these criteria were assessed for the following outcome measures: frequency of positive PA cultures; serum level of precipitating antibodies; lung function; survival; number of hospitalisations; adverse effects and resistance to antibiotics. Results: Of the 11 studies eventually considered, 3 were randomised - 2 versus placebo - and 8 were cohort studies - 2 of which had historical controls. Overall, 309 patients (population range 7-91 patients) were recruited. There was a high variability between the individual studies for age, outcome measures, duration of follow-up (1 to 44 months) and treatment (three studies used only aerosol tobramycin, one colistin, four aerosol colistin plus oral ciprofloxacin, one used intravenous treatment and two miscellaneous therapy). An overall evaluation indicated that early antibiotic treatment can reduce the number of positive cultures and the anti-PA antibody titre. In one study, FEV1 was better in the treated group (oral ciprofloxacin and nebulised colistin) than in historical controls, while in one placebo-controlled trial, no effect on lung function was shown after 1 year of tobramycin inhalation. Collateral effects and bacterial resistance were not increased. The short follow-up did not allow definite conclusions with regard to the long-term progression of respiratory insufficiency or survival. Conclusions: Evidence was found that antibiotic treatment can reduce the rate of positive cultures and of anti-PA antibody titres in asymptomatic CF patients with newly isolated PA. Different therapeutic options have not been directly compared: a multi-centre comparative study needs to be carried out.

Original languageEnglish
Pages (from-to)67-74
Number of pages8
JournalEuropean Journal of Clinical Pharmacology
Volume60
Issue number2
DOIs
Publication statusPublished - Apr 2004

Fingerprint

Cystic Fibrosis
Pseudomonas aeruginosa
Anti-Bacterial Agents
Colistin
Tobramycin
Therapeutics
Ciprofloxacin
Aerosols
Publications
Antibodies
Placebos
Outcome Assessment (Health Care)
Lung
Survival
Microbial Drug Resistance
Respiratory Insufficiency
Inhalation
Hospitalization
Cohort Studies
Language

Keywords

  • Bacterial colonisation
  • Cystic fibrosis
  • Pseudomonas aeruginosa

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis : A critical review of the literature. / Marchetti, Federico; Giglio, Luisella; Candusso, Manila; Faraguna, Dino; Assael, Baroukh M.

In: European Journal of Clinical Pharmacology, Vol. 60, No. 2, 04.2004, p. 67-74.

Research output: Contribution to journalArticle

@article{2813fd8803ee4827a25ab9e2c8702c74,
title = "Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: A critical review of the literature",
abstract = "Aim: To assess the evidence supporting early antibiotic treatment in asymptomatic cystic fibrosis (CF) patients colonised by Pseudomonas aeruginosa (PA). Methods: We carried out a computerised (Medline, Embase) and hand search of journals for suitable publications. All English-language clinical studies regarding the efficacy of early antibiotic treatment on PA colonisation in asymptomatic patients were considered. Each eligible publications fitting these criteria were assessed for the following outcome measures: frequency of positive PA cultures; serum level of precipitating antibodies; lung function; survival; number of hospitalisations; adverse effects and resistance to antibiotics. Results: Of the 11 studies eventually considered, 3 were randomised - 2 versus placebo - and 8 were cohort studies - 2 of which had historical controls. Overall, 309 patients (population range 7-91 patients) were recruited. There was a high variability between the individual studies for age, outcome measures, duration of follow-up (1 to 44 months) and treatment (three studies used only aerosol tobramycin, one colistin, four aerosol colistin plus oral ciprofloxacin, one used intravenous treatment and two miscellaneous therapy). An overall evaluation indicated that early antibiotic treatment can reduce the number of positive cultures and the anti-PA antibody titre. In one study, FEV1 was better in the treated group (oral ciprofloxacin and nebulised colistin) than in historical controls, while in one placebo-controlled trial, no effect on lung function was shown after 1 year of tobramycin inhalation. Collateral effects and bacterial resistance were not increased. The short follow-up did not allow definite conclusions with regard to the long-term progression of respiratory insufficiency or survival. Conclusions: Evidence was found that antibiotic treatment can reduce the rate of positive cultures and of anti-PA antibody titres in asymptomatic CF patients with newly isolated PA. Different therapeutic options have not been directly compared: a multi-centre comparative study needs to be carried out.",
keywords = "Bacterial colonisation, Cystic fibrosis, Pseudomonas aeruginosa",
author = "Federico Marchetti and Luisella Giglio and Manila Candusso and Dino Faraguna and Assael, {Baroukh M.}",
year = "2004",
month = "4",
doi = "10.1007/s00228-004-0735-2",
language = "English",
volume = "60",
pages = "67--74",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis

T2 - A critical review of the literature

AU - Marchetti, Federico

AU - Giglio, Luisella

AU - Candusso, Manila

AU - Faraguna, Dino

AU - Assael, Baroukh M.

PY - 2004/4

Y1 - 2004/4

N2 - Aim: To assess the evidence supporting early antibiotic treatment in asymptomatic cystic fibrosis (CF) patients colonised by Pseudomonas aeruginosa (PA). Methods: We carried out a computerised (Medline, Embase) and hand search of journals for suitable publications. All English-language clinical studies regarding the efficacy of early antibiotic treatment on PA colonisation in asymptomatic patients were considered. Each eligible publications fitting these criteria were assessed for the following outcome measures: frequency of positive PA cultures; serum level of precipitating antibodies; lung function; survival; number of hospitalisations; adverse effects and resistance to antibiotics. Results: Of the 11 studies eventually considered, 3 were randomised - 2 versus placebo - and 8 were cohort studies - 2 of which had historical controls. Overall, 309 patients (population range 7-91 patients) were recruited. There was a high variability between the individual studies for age, outcome measures, duration of follow-up (1 to 44 months) and treatment (three studies used only aerosol tobramycin, one colistin, four aerosol colistin plus oral ciprofloxacin, one used intravenous treatment and two miscellaneous therapy). An overall evaluation indicated that early antibiotic treatment can reduce the number of positive cultures and the anti-PA antibody titre. In one study, FEV1 was better in the treated group (oral ciprofloxacin and nebulised colistin) than in historical controls, while in one placebo-controlled trial, no effect on lung function was shown after 1 year of tobramycin inhalation. Collateral effects and bacterial resistance were not increased. The short follow-up did not allow definite conclusions with regard to the long-term progression of respiratory insufficiency or survival. Conclusions: Evidence was found that antibiotic treatment can reduce the rate of positive cultures and of anti-PA antibody titres in asymptomatic CF patients with newly isolated PA. Different therapeutic options have not been directly compared: a multi-centre comparative study needs to be carried out.

AB - Aim: To assess the evidence supporting early antibiotic treatment in asymptomatic cystic fibrosis (CF) patients colonised by Pseudomonas aeruginosa (PA). Methods: We carried out a computerised (Medline, Embase) and hand search of journals for suitable publications. All English-language clinical studies regarding the efficacy of early antibiotic treatment on PA colonisation in asymptomatic patients were considered. Each eligible publications fitting these criteria were assessed for the following outcome measures: frequency of positive PA cultures; serum level of precipitating antibodies; lung function; survival; number of hospitalisations; adverse effects and resistance to antibiotics. Results: Of the 11 studies eventually considered, 3 were randomised - 2 versus placebo - and 8 were cohort studies - 2 of which had historical controls. Overall, 309 patients (population range 7-91 patients) were recruited. There was a high variability between the individual studies for age, outcome measures, duration of follow-up (1 to 44 months) and treatment (three studies used only aerosol tobramycin, one colistin, four aerosol colistin plus oral ciprofloxacin, one used intravenous treatment and two miscellaneous therapy). An overall evaluation indicated that early antibiotic treatment can reduce the number of positive cultures and the anti-PA antibody titre. In one study, FEV1 was better in the treated group (oral ciprofloxacin and nebulised colistin) than in historical controls, while in one placebo-controlled trial, no effect on lung function was shown after 1 year of tobramycin inhalation. Collateral effects and bacterial resistance were not increased. The short follow-up did not allow definite conclusions with regard to the long-term progression of respiratory insufficiency or survival. Conclusions: Evidence was found that antibiotic treatment can reduce the rate of positive cultures and of anti-PA antibody titres in asymptomatic CF patients with newly isolated PA. Different therapeutic options have not been directly compared: a multi-centre comparative study needs to be carried out.

KW - Bacterial colonisation

KW - Cystic fibrosis

KW - Pseudomonas aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=2442457749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442457749&partnerID=8YFLogxK

U2 - 10.1007/s00228-004-0735-2

DO - 10.1007/s00228-004-0735-2

M3 - Article

C2 - 15004732

AN - SCOPUS:2442457749

VL - 60

SP - 67

EP - 74

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 2

ER -